PubMed Health⌕ Search

Biomedical subjects

Y Machida

Publications and source records attributed to Y Machida.

At least 145 records · Page 8Linked to original sources

The promoter proximal region in the virD locus of Agrobacterium tumefaciens is necessary for the plant-inducible circularization of T-DNA.

The formation of crown gall tumours involves the transfer of the T-DNA region of the Ti plasmid from Agrobacterium to plant cells and its subsequent integration into plant chromosomes. When agrobacteria are incubated with plant protoplasts or exudates of plants, the T-DNA region is circularized by recombination or cleavage and rejoining between the 25 bp terminal repeats; the formation of circular T-DNAs is thought to be one step in T-DNA transfer (Koukolikova-Nicola et al. 1985; Machida et al. 1986). We previously showed that the virulence region of the Ti plasmid is required for T-DNA circularization. In the present paper, we examined the circularization event in agrobacteria harbouring octopine Ti plasmids with mutations in various loci of the virulence region. The results clearly demonstrate that the gene(s) encoded in the virD locus are necessary for T-DNA circularization. In particular, the gene(s) present in the region proximal to the virD promoter are essential. We propose that product(s) of this gene have recombinase or endonuclease activity which specifically recognizes the 25 bp terminal repeats of T-DNA.

DNA, Bacterial↗

Double-layered stick-type formulation of bleomycin for treatment of uterine cervical cancer.

The possibility of continuous release over one week of drugs applied topically was investigated using new stick-type formulations of Brilliant Blue (BB) or bleomycin hydrochloride (BLM). Double-layered sticks of BB or BLM able to adhere to mucosa were prepared by direct compression of the drug, hydroxypropylcellulose-H (HPC) and a carboxyvinyl polymer (Carbopol 934). Drug release in vitro from the sticks was delayed by increasing the weight of the outer layer or the amount of HPC in the outer layer. The sustained release achieved with a double-layered stick having a core coated with an acrylate copolymer (MPM) suggests the possibility of once-a-week treatment of uterine cervical cancer.

Benzenesulfonates↗

Enhanced percutaneous absorption of ionizable water-soluble drugs.

The percutaneous absorption of diltiazem hydrochloride (DIL) and disodium cromoglycate (DSCG) [representative, respectively, of cationic and anionic water-soluble drugs] was studied in rabbits, using films prepared from water-soluble components. When corresponding fat-soluble counter-ions were added to films prepared using the electrically neutral components polyvinylalcohol and glycerol, the percutaneous absorption of the drugs was enhanced. Furthermore, when non-electrolytes such as BL-9EX or urea were added to the films together with the counter-ions, the bioavailability of the drugs increased. Consequently, it is postulated that ionizable water-soluble drugs are absorbed through skin by forming fat-soluble ion-pairs and additionally that the barrier function against absorption is reduced by non-electrolytes such as BL-9EX or urea. Such non-electrolytes must not hinder the formation of ion-pairs between the drugs and corresponding counter-ions.

Animals↗

Preparation of polylactic acid-polylipoic acid nanospheres as drug targeting carriers.

Polylactic acid-polylipoic acid nanospheres (PLA-PLIA-NS) were prepared, and their properties as drug targeting dosage forms were evaluated. A computer optimization technique was applied to obtain particles with nanometer order diameters and spherical shapes. Optimum preparative conditions involved the use of 2.4% hydroxypropyl cellulose (HPC), as a stabilizing agent, 24 min ultrasonication time, and 20% PLIA content. PLIA, containing a thiol group, was used for the conjugation of antibodies with the PLA-PLIA-NS surface. In this way, fairly spherical particles of PLA-PLIA-NS with a mean diameter of about 500 nm were obtained. The conjugation was investigated to determine targeting ability more precisely. Using rabbit antihuman IgG (Fab' fragment) antibodies, conjugation with PLA-PLIA-NS was accomplished by a disulphide binding reaction. The PLA-PLIA-NS-antibody conjugates were found to recognize IgG antigen bound to the surface of Sepharose beads.

Drug Carriers↗

Use of soybean protein for controlled release of drugs administered orally.

The influence of soybean protein (SBP) on the release of drugs from per-oral formulations was investigated, using dl-propranolol as model drug. Directly compressed tablets of SBP/lactose containing more than 40% of SBP did not disintegrate and kept their shape for long periods. Then, dissolution tests (JPX) were carried out with similar tablets containing dl-propranolol hydrochloride as active ingredient. The dissolution profiles showed sustained release of the drug, the dissolution rate being prolonged with increasing amounts of added SBP. Dissolution was affected by the pH of the test medium and accelerated by addition of pancreatin to the test medium. Our results suggest that interaction between SBP, drug and lactose may influence the dissolution rate. Dissolution was unaffected by varying compressional pressure (100-300 kg/cm2) in the preparation of tablets.

Administration, Oral↗